Teva Pharmaceutical Industries (TEVA) EBIT Growth (3y) (2012 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) EBIT Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn | 29.31% |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -74.25% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -42.93% |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn | 17.46% |
| 5 | Bausch Health Companies | 2.37 Bn | 528.25 Mn | 2.10 Bn | 21.56% |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 48.31% |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 2.50% |
| 9 | Fennec Pharmaceuticals | 411.43 Mn | 370.18 Mn | 17.15 Mn | 33.37% |
| 10 | RedHill Biopharma | 181.39 Mn | 181.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.31% |
| Mar 31, 2026 | 273.62% |
| Dec 31, 2025 | 32.37% |
| Sep 30, 2025 | 27.65% |
| Jun 30, 2025 | 35.19% |
| Mar 31, 2025 | 39.73% |
| Dec 31, 2024 | -33.36% |
| Sep 30, 2024 | -27.69% |
| Jun 30, 2024 | -26.17% |
| Mar 31, 2024 | -35.76% |
| Dec 31, 2023 | 23.03% |
| Sep 30, 2023 | 27.63% |
| Jun 30, 2023 | -79.47% |
| Mar 31, 2023 | -27.41% |
| Dec 31, 2022 | -102.89% |
| Sep 30, 2022 | 93.41% |
| Jun 30, 2022 | -14.51% |
| Mar 31, 2022 | -94.17% |
| Dec 31, 2021 | 26.51% |
| Sep 30, 2021 | 238.94% |